Submissions from 2024
How To Limit The Downstream Costs Of Racially Restrictive Covenants, Randall K. Johnson
Partisan Judges, Steve Leben
The Persistent Treatise, Dana Neacsu and Paul D. Callister
Marketing the Modern Law Librarian, Ariel Newman
Dispute Resolution and Family Law: An Annotated Bibliography, Allen Roston
International Issues in Family Law: An Annotated Bibliography, Allen Rostron
Saints, Satanists, and Religious Public Charter Schools, Allen Rostron
Behaviour Of Creditors And Involved Stakeholders In Corporate Insolvency Resolution Process (CIRP) In India: An Economic Perspective, Hiteshkumar Thakkar, Pranay Agarwal, and Randall K. Johnson
Submissions from 2023
The Importance of Member Participation in the AALL Salary Survey, Kathleen Brown, Deanna Barmakian, and Ariel Newman
Tenancy by the Entirety Property and Transfers to Trusts, Julie M. Cheslik
The Retail Investor Report, Nick Einhorn, Jill E. Fisch, Sergio Alberto Gramitto Ricci, Monique Le, and Christina M. Sautter
Introduction: The Arc of Race in Professional and Collegiate Sports Symposium, Kenneth D. Ferguson
The Ethical Risk of Experience, Barbara Glesner Fines
Comment Letter on SEC’s Proposed Rule on Conflicts of Interest Associated with the Use of Predictive Data Analytics by Broker-Dealers and Investment Advisers, File Number S7-12-23, Sergio Alberto Gramitto Ricci and Christina M. Sautter
New Hollywood blockbuster depicts a triumph for savvy retail investors but it's just the beginning, Sergio Alberto Gramitto Ricci and Christina M. Sautter
Wireless Investors & Apathy Obsolescence, Sergio Alberto Gramitto Ricci and Christina M. Sautter
Why U.S. States Need Their Own Cannabis Industry Banks, Christoph Henkel and Randall K. Johnson
A 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar Competition, Christopher M. Holman
Federal Circuit Reiterates That Drug Safety and Efficacy Are Issues for the FDA, Not the Patent Laws, Christopher M. Holman
Recent Developments at the Intersection of Pharma, Patents, and Antitrust Law, Christopher M. Holman
Recent Developments in FDA Regulatory Exclusivities, Christopher M. Holman
Recent Developments in the Listing of Patents in FDA's Orange Book, Christopher M. Holman
To What Extent Does Mayo v. Prometheus Allow for the Patenting of Diagnostic Methods?, Christopher M. Holman
Tax-Free Transfers From IRAs To CRTs and CGAs, Christopher R. Hoyt
Ella P. Stewart And The Benefits Of Owning A Neighborhood Pharmacy, Randall K. Johnson